- ADM opened a new extrusion facility in Serbia less than a year after acquiring SojaProtein.
- The facility will produce non-GMO textured soy protein, with 90% of soy sourced locally.
- The EMEA meat alternatives market was valued at $3 billion in 2021, with a projected CAGR of 11.8% from 2021 to 2026.
- ADM recently invested $300 million to expand its alternative protein production in Decatur, Illinois.
New Facility in Serbia
ADM has opened a new extrusion facility in Serbia, enhancing its production capabilities for non-GMO textured soy proteins. This development follows ADM's acquisition of SojaProtein, a European provider of non-GMO soy ingredients, less than a year ago.
Local Sourcing and Production
The new facility will produce non-GMO soy proteins, with 90% of the soy sourced from within 100 kilometers of the plant. This local supply chain supports the high demand for non-GMO soy protein in Europe and globally, where 75% of consumers seek non-GMO claims on protein content.
Market Growth and Demand
The meat alternatives market in the EMEA region is expanding rapidly, with a market value of $3 billion at the end of 2021 and an anticipated compound annual growth rate (CAGR) of 11.8% between 2021 and 2026. The new facility aims to meet this growing demand by providing high-quality, non-GMO soy protein solutions for plant-based savory offerings.
Global Expansion
ADM's new facility in Serbia complements its existing extrusion and texturized capacities in North America. The company has also announced a substantial investment of $300 million to expand its alternative protein production in Decatur, Illinois, and plans to open a new Protein Innovation Center.
